Knee relief choices differ in time, cost and effort

Exercise and medicine are the usual starting points

Regular exercise can support strength and movement, even when you need to start slowly. It shouldn't leave the knee sharply worse or much more swollen afterward.

Medicine rubbed on the knee or taken by mouth may help when it's safe for you. Your regular doctor can check it against your other medicines and health problems.

Home care still matters if you later choose a procedure or an operation. Stronger legs can ease daily movement, and you'll know what has or hasn't helped.

Relief, visits and cost aren't the same for cortisone, gel and PRP

Cortisone may work quickly, though the relief often fades with time. It isn't worth repeating from habit when the last shot gave little comfort.

Gel is made to act like the slippery fluid in your joint. Large reviews found so little change in soreness and daily movement that many patients wouldn't notice much help.

PRP is short for platelet-rich plasma, the liquid part of your blood after the clinic spins a sample and gathers extra platelets into one small amount before placing it in the knee. That's how PRP is prepared.

Some comparisons found better relief with PRP, but one large test found no better soreness than a salt-water shot. Ask what each choice may change, how many visits it takes and what the full cost covers.

When the knee stays sore, QC Kinetix can review non-surgical choices

QC Kinetix offers biologic therapies, meaning care made from a sample of your blood and placed into the sore knee without surgery. The medical providers who examine the knee may discuss regenerative treatments such as PRP.

The choices may include PRP and concentrated PRP, which gathers more platelets into the prepared amount. Both start with your blood, and the clinic can explain why one is being proposed.

These are knee surgery alternatives, not a promise that you'll never need replacement. Before paying, ask about the visits, recovery time, total price and when you can judge relief.

Sources

1. The 2015 Cochrane review of 27 trials (1,767 participants) found intra-articular corticosteroid better than sham for knee OA pain (SMD -0.40, 95% CI -0.58 to -0.22; NNTB 8), but the benefit decayed with time: moderate at 1-2 weeks, small at 13 weeks, and no evidence of any effect at 26 weeks. All outcomes were graded LOW quality.

   Jüni P, et al. — Intra-articular corticosteroid for knee osteoarthritis.. Cochrane Database Syst Rev, 2015. DOI: 10.1002/14651858.CD005328.pub3.

2. A 2022 BMJ systematic review and meta-analysis of 169 trials (21,163 participants) found viscosupplementation produced only a small pain reduction versus placebo (SMD -0.08, 95% CI -0.15 to -0.02; about -2.0 mm on a 100 mm VAS), below the minimal clinically important difference, and trial sequential analysis indicated conclusive evidence of clinical equivalence with placebo since 2009.

   Pereira TV, et al. — Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.. BMJ, 2022. DOI: 10.1136/bmj-2022-069722.

3. The RESTORE randomized trial (288 participants, leukocyte-poor PRP, 3 weekly injections) found no significant difference from saline placebo at 12 months in knee pain (-2.1 vs -1.8 points; difference -0.4, 95% CI -0.9 to 0.2) or in medial tibial cartilage volume (-1.4% vs -1.2%), with 29 of 31 secondary outcomes also showing no between-group difference.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

4. A 2024 network meta-analysis of 48 studies (9,338 knees) at minimum 6-month follow-up ranked PRP first for pain and function (SUCRA 91.5), then BMAC (76.5) and hyaluronic acid (53.1), with corticosteroid (15.2) barely above placebo (13.7) at that time point.

   Jawanda H, et al. — Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.. Arthroscopy, 2024. DOI: 10.1016/j.arthro.2024.01.037.

5. A systematic review of ultrasound versus anatomic (landmark) guidance found needle-placement accuracy was greater with ultrasound guidance at every anatomic site, and short-term (<6 weeks) symptom onset improved, but long-term outcomes were NOT shown to differ between the two techniques; the accuracy advantage was largest in small joints.

   Gilliland CA, et al. — Ultrasound versus anatomic guidance for intra-articular and periarticular injection: a systematic review.. Phys Sportsmed, 2011. DOI: 10.3810/psm.2011.09.1928.

6. A 2021 JAMA review of hip and knee osteoarthritis places intra-articular steroid injections as providing SHORT-TERM pain relief within a management model whose cornerstones are exercise, weight loss if appropriate and education, complemented by topical or oral NSAIDs, with joint replacement reserved for advanced symptoms and structural damage.

   Katz JN, et al. — Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.. JAMA, 2021. DOI: 10.1001/jama.2020.22171.